Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Goodsaid

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2013
The current status of biomarkers for predicting toxicitySarah Campion, Jiri Aubrecht, Kim Boekelheide, et al.
NPJ Genomic Medicine|January 23, 2018
A robust targeted sequencing approach for low input and variable quality DNA from clinical samplesAustin P So, Anna Vilborg, Yosr Bouhlal, et al.
Nature Reviews. Drug Discovery|November 1, 2011
Quantifying factors for the success of stratified medicineMark R Trusheim, Breon Burgess, Sean Xinghua Hu, et al.
Omics : a Journal of Integrative Biology|May 2, 2008
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?"Susanna-Assunta Sansone, Philippe Rocca-Serra, Marco Brandizi, et al.
Plos One|September 13, 2012
Technical reproducibility of genotyping SNP arrays used in genome-wide association studiesHuixiao Hong, Lei Xu, Jie Liu, et al.
Nature Biotechnology|May 12, 2010
Towards consensus practices to qualify safety biomarkers for use in early drug developmentFrank D Sistare, Frank Dieterle, Sean Troth, et al.
Nature Methods|September 24, 2005
The External RNA Controls Consortium: a progress reportShawn C Baker, Steven R Bauer, Richard P Beyer, et al.
Nature Biotechnology|May 12, 2010
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing ConsortiumFrank Dieterle, Frank Sistare, Federico Goodsaid, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2013
The current status of biomarkers for predicting toxicitySarah Campion, Jiri Aubrecht, Kim Boekelheide, et al.
NPJ Genomic Medicine|January 23, 2018
A robust targeted sequencing approach for low input and variable quality DNA from clinical samplesAustin P So, Anna Vilborg, Yosr Bouhlal, et al.
Nature Reviews. Drug Discovery|November 1, 2011
Quantifying factors for the success of stratified medicineMark R Trusheim, Breon Burgess, Sean Xinghua Hu, et al.
Omics : a Journal of Integrative Biology|May 2, 2008
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?"Susanna-Assunta Sansone, Philippe Rocca-Serra, Marco Brandizi, et al.
Plos One|September 13, 2012
Technical reproducibility of genotyping SNP arrays used in genome-wide association studiesHuixiao Hong, Lei Xu, Jie Liu, et al.
Nature Biotechnology|May 12, 2010
Towards consensus practices to qualify safety biomarkers for use in early drug developmentFrank D Sistare, Frank Dieterle, Sean Troth, et al.
Nature Methods|September 24, 2005
The External RNA Controls Consortium: a progress reportShawn C Baker, Steven R Bauer, Richard P Beyer, et al.
Nature Biotechnology|May 12, 2010
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing ConsortiumFrank Dieterle, Frank Sistare, Federico Goodsaid, et al.
Pageof 3